Page last updated: 2024-09-05

naphthalene-1,5-dimaleimide and Glioma

naphthalene-1,5-dimaleimide has been researched along with Glioma in 1 studies

*Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bracci, P; Christensen, BC; Clarke, J; Hansen, H; Kelsey, KT; Koestler, DC; McCoy, L; Molinaro, AM; Nissen, E; Rice, T; Salas, LA; Tamaki, CM; Tamaki, SJ; Tang, E; Taylor, JW; Warrier, G; Wiencke, JK; Wrensch, M; Zhang, Z1

Other Studies

1 other study(ies) available for naphthalene-1,5-dimaleimide and Glioma

ArticleYear
DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival.
    Nature communications, 2022, 09-20, Volume: 13, Issue:1

    Topics: Biomarkers; Dexamethasone; DNA Methylation; Glioma; Glucocorticoids; Humans; Maleimides; Prednisone

2022